A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities
Endocrine conditions, such as hypothyroidism, can cause or contribute to constipation (Basilisco 2013
Trastornos tiroideos no controlados
Understanding Semaglutide, its mechanism of action, and its role in diabetes management is crucial for both healthcare professionals and patients
Its a simple step that professionals never skip
Overall movement Even beyond exercise, simply moving more in general can lead to more calories burned and weight lost